Skip to main content

Table 1 Distribution of participants (all with diabetes) at baseline visit in 2005–2007, and distribution and cause of not participating at follow-up visit in 2015

From: Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study

  Groups with diabetes and Charcot foot Groups with diabetes but without Charcot foot
Distribution of participants at baseline visit 2005–2007a Acute CF (n = 17) Chronic CF (n = 7) 1. toe amputee (n = 5) Neuropathy (n = 9) Without neuropathy (n = 11)
 Passed away before follow-up 3 (17%) 3 (43%) 3 (60%) 3 (33%) 0 (0%)
 How many were amputated before death 2 2 1 0 N/A
 Unable to reach/moved abroad 1 1 1 0 1
 Declined participation 2 0 1 2 2
 Excluded due to amputation 1 2 0 1 0
 Participants available for follow-up measurements 10 1 0 3 8
Distribution of participants at follow-up visit 2015 Previous Charcot foot (DM + CF)
n = 11
No previous Charcot foot (DM − CF)
n = 11
  1. aPlease see [11, 18] for details